These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34513681)

  • 1. Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study.
    Latorzeff I; Bruguière E; Bogart E; Le Deley MC; Lartigau E; Marre D; Pasquier D
    Front Oncol; 2021; 11():701998. PubMed ID: 34513681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol.
    Pasquier D; Bogart E; Bonodeau F; Lacornerie T; Lartigau E; Latorzeff I
    BMC Cancer; 2018 May; 18(1):566. PubMed ID: 29769060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer.
    Ahmad Khalil D; Jazmati D; Geismar D; Wulff J; Bäumer C; Kramer PH; Steinmeier T; Schulze Schleitthoff S; Plaude S; Bischoff M; Tschirdewahn S; Hadaschik B; Timmermann B
    Radiat Oncol; 2022 Apr; 17(1):64. PubMed ID: 35365170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy.
    Costa P; Vale J; Fonseca G; Costa A; Kos M
    Tech Innov Patient Support Radiat Oncol; 2024 Mar; 29():100237. PubMed ID: 38322778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?
    Teh BS; McGary JE; Dong L; Mai WY; Carpenter LS; Lu HH; Chiu JK; Woo SY; Grant WH; Butler EB
    Cancer J; 2002; 8(6):476-83. PubMed ID: 12500857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
    Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
    Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.
    Dinh TT; Lee HJ; Macomber MW; Apisarnthanarax S; Zeng J; Laramore GE; Rengan R; Russell KJ; Chen JJ; Ellis WJ; Schade GR; Liao JJ
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):635-643. PubMed ID: 32035187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, Randomized, Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy.
    Song D; Dabkowski M; Costa P; Nurani R; Kos M; Vanneste B; Magel D; Sapir E; Zimberg S; Boychak O; Soffen E; Alhasso A; Tokita K; Wang D; Symon PZ; Hudes R
    Int J Radiat Oncol Biol Phys; 2024 Jul; ():. PubMed ID: 39032758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for rectal bleeding after volumetric-modulated arc radiotherapy of prostate cancer.
    Otsuka K; Otsuka M; Itaya T; Matsumoto A; Sato R; Sagara Y; Oga M; Asayama Y
    Rep Pract Oncol Radiother; 2023; 28(1):15-23. PubMed ID: 37122916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy.
    Chao M; Ho H; Chan Y; Tan A; Pham T; Bolton D; Troy A; Temelcos C; Sengupta S; McMillan K; Cham CW; Liu M; Ding W; Subramanian B; Wasiak J; Lim Joon D; Spencer S; Lawrentschuk N
    BJU Int; 2018 Sep; 122(3):427-433. PubMed ID: 29520983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers.
    Schörghofer A; Drerup M; Kunit T; Lusuardi L; Holzinger J; Karner J; Groher M; Zoubek C; Forstner R; Sedlmayer F; Wolf F
    Radiat Oncol; 2019 Mar; 14(1):47. PubMed ID: 30876433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of rectal balloon-filling materials on the dosimetry of prostate and organs at risk in photon beam therapy.
    Srivastava SP; Das IJ; Kumar A; Johnstone PA; Cheng CW
    J Appl Clin Med Phys; 2013 Jan; 14(1):3993. PubMed ID: 23318385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study.
    Sakurai T; Takamatsu S; Shibata S; Taka M; Ishiyama M; Yamazaki M; Kojima H; Mizokami A; Kumano T; Gabata T
    Brachytherapy; 2021; 20(3):584-594. PubMed ID: 33485811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study.
    Gez E; Cytron S; Ben Yosef R; London D; Corn BW; Alani S; Scarzello G; Dal Moro F; Sotti G; Zattoni F; Koziol I; Torre T; Bassignani M; Kalnicki S; Ghavamian R; Blakaj D; Anscher M; Sommerauer M; Jocham D; Melchert C; Huttenlocher S; Kovacs G; Garg M
    Radiat Oncol; 2013 Apr; 8():96. PubMed ID: 23618548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
    Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
    Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
    Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
    Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.